AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Journal of Traditional Chinese Medical Sciences Article
PDF (229.6 KB)
Cite
EndNote(RIS) BibTeX
Collect
AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Perspective | Open Access

Application of evidence-based medicine methods in integrative oncology research

Jianping Liua,1( ), Sijia Zhua,1, Nicola Robinsonb
Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China
School of Health and Social Care, London South Bank University, London, SE1 0AA, United Kingdom

1 The two authors contributed equally to this work.

Peer review under responsibility of Beijing University of Chinese Medicine.

Show Author Information

Abstract

To present the advances of evidence-based medicine and clinical research methodology in integrative oncology, we conducted a literature review of real-world studies of traditional Chinese medicine (TCM) in cancer care and summarized the available evidence. Pragmatic randomized controlled trials (pRCTs) and clinical registry studies are becoming more popular as they could compensate for the limitations of RCTs. Many RCTs of TCM for cancer treatment as well as systematic reviews have been published. The most investigated therapies are based on acupuncture, Chinese herbal compounds, and Chinese patent medicines. Acupuncture has a significant advantage in relieving cancer-related symptoms. Published studies focus more on improving clinical symptoms and laboratory indicators. However, the patient's quality of life deserves more attention.

Keywords

Traditional Chinese medicineEvidence-based medicineIntegrative oncologyResearch designPragmatic clinical trialRegistries

References

1

Cochrane AL. Archie cochrane in his own words. Selections arranged from his 1972 introduction to “effectiveness and efficiency: random reflections on the health services” 1972. Contr Clin Trials. 1989;10(4): 428-433.
Crossref Google Scholar
2

Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet. 2017;390(10092): 415-423.
Crossref Google Scholar
3

Guyatt G. Evidence-based medicine. ACP J Club. 1991;114(suppl 2): A16.
Crossref Google Scholar
4

Montori VM, Guyatt GH. What is evidence-based medicine? Endocrinol Metab Clin N Am. 2002;31(3): 521-526. ⅶ.
Crossref Google Scholar
5

Bauer MS, Kirchner J. Implementation science: what is it and why should I care? Psychiatr Res. 2020;283: 112376.
Crossref Google Scholar
6
Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions (version 6.3). Cochrane training web site; 2022. Updated February http://www.training.cochrane.org/handbooks. Accessed December 10, 2022.
7

Tricco AC, Antony J, Zarin W, et al. A scoping review of rapid review methods. BMC Med. 2015;13:224.
Crossref Google Scholar
8

Giovagnoni A, Bartolucci L, Manna A, Morbiducci J, Ascoli G. Health technology assessment: principles, methods and current status. Radiol Med. 2009;114(5):673-691.
Crossref Google Scholar
9

Rose N, Pang DSJ. A practical guide to implementing clinical audit. Can Vet J. 2021;62(2):145-152.
Google Scholar
10
Tenny S, Brannan JM, Brannan GD. Qualitative study. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
11

Baumfeld AE, Reynolds R, Caubel P, Azoulay L, Dreyer NA. Trial designs using real-world data: the changing landscape of the regulatory approval process. Pharmacoepidemiol Drug Saf. 2020;29(10):1201-1212.
Crossref Google Scholar
12

Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and impact of real-world clinical data for the practicing clinician. Adv Ther. 2018;35(11):1763-1774.
Crossref Google Scholar
13

Ahmad T, Yamamoto Y, Biswas A, et al. REVeAL-HF: design and rationale of a pragmatic randomized controlled trial embedded within routine clinical practice. JACC Heart Fail. 2021;9(6):409-419.
Crossref Google Scholar
14

He Y, May BH, Zhang AL, et al. Acupuncture for cancer pain: protocol for a pilot pragmatic randomised controlled trial. BMJ Open. 2019;9(7):e025564.
Crossref Google Scholar
15

Laugsand TS, Kaasa S, Romundstad P, Johannesen TB, Lund JÅ. Radiotherapy for bone metastases: practice in Norway 1997-2007. A national registry-based study. Acta Oncol. 2013;52(6):1129-1136.
Crossref Google Scholar
16

Melin J, Tiitinen A, Hirvonen E, et al. Probability of live birth after IVF/ICSI treatments in female early onset cancer survivors: a Finnish population-based registry study. Hum Reprod. 2021;36(12):3131-3140.
Crossref Google Scholar
17

Han YL, Chen JY, Xu B, et al. Real world clinical performance of the zotarolimus eluting coronary stent system in Chinese patients: a prospective, multicenter registry study. Chin Med J. 2011;124(20):3255-3259.
Google Scholar
18

Charrow J, Andersson HC, Kaplan P, et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med. 2000;160(18):2835-2843.
Crossref Google Scholar
19

Zhang XW, Hou WB, Pu FL, et al. Acupuncture for cancer-related conditions: an overview of systematic reviews. Phytomedicine. 2022;106:154430.
Crossref Google Scholar
20
Li X, Yang G, Li X, et al. Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in Chinese. PLoS One. 2013;8(4): e60338. Erratum in: PLoS One 2013;8(6). https://doi.org/10.1371/annotation/b53a0b8b-3eb6-44a2-9c37-bc9bb66bfe7e. Accessed December 10, 2022
Crossref
21

Mokhtari-Hessari P, Montazeri A. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcome. 2020;18(1):338.
Crossref Google Scholar
22

Mao JJ, Pillai GG, Andrade CJ, et al. Integrative oncology: addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144-164.
Crossref Google Scholar
23

Fethney J. Statistical and clinical significance, and how to use confidence intervals to help interpret both. Aust Crit Care. 2010;23(2):93-97.
Crossref Google Scholar
Journal of Traditional Chinese Medical Sciences
Volume 10 Issue 2,
April 2023
Pages 129-132
DOI: 10.1016/j.jtcms.2023.03.001
Cite this article:
Liu J, Zhu S, Robinson N. Application of evidence-based medicine methods in integrative oncology research. Journal of Traditional Chinese Medical Sciences, 2023, 10(2): 129-132. https://doi.org/10.1016/j.jtcms.2023.03.001

284

Views

9

Downloads

0

Crossref

0

Scopus

Altmetrics
Received: 28 January 2023
Revised: 05 March 2023
Accepted: 06 March 2023
Published: 11 March 2023
© 2023 Beijing University of Chinese Medicine.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return